Skip to main content
. 2023 Jan 5;14(1):565–575. doi: 10.1002/jcsm.13160

Table 2.

Participant characteristics among white men

Characteristic [mean (SD) or N(%)] All cohorts (n = 9170) Health ABC (n = 908) MrOS US (n = 5064) MrOS Sweden (n = 2851) HCS (n = 157) SarcoPhAge (n = 190)
Age (years) 74.3 (4.9) 74.4 (2.9) 73.8 (5.9) 74.9 (3.1) 75.3 (2.5) 73.6 (6.1)
Height (cm) 174.4 (6.6) 173.4 (6.2) 174.5 (6.6) 174.8 (6.5) 173.9 (6.2) 171.8 (6.3)
Weight (kg) 82.3 (12.6) 81.2 (12.3) 83.5 (12.9) 80.5 (11.8) 82.3 (11.7) 81.4 (15.0)
BMI (kg/m2) 27.0 (3.7) 27.0 (3.7) 27.4 (3.8) 26.3 (3.5) 27.2 (3.6) 27.5 (4.6)
ALM (kg) 24.2 (3.3) 23.2 (3.2) 24.3 (3.4) 24.2 (3.2) 24.3 (2.7) 23.4 (3.8)
ALM index (kg/m2) 7.9 (0.9) 7.7 (0.9) 8.0 (0.9) 7.9 (0.8) 8.0 (0.7) 7.9 (1.1)
Grip strength (kg) 41.7 (8.3) 39.5 (7.7) 41.6 (8.5) 43.0 (7.8) 37.2 (7.2) 39.0 (9.5)
Gait speed (m/s) 1.27 (0.25) 1.29 (0.23) 1.25 (0.23) 1.32 (0.25) 0.82 (0.18) 1.05 (0.29)
Original sarcopenia definitions
EWGSOP2 105 (1.1%) 14 (1.5%) 69 (1.4%) 13 (0.5%) 0 (0.0%) 9 (4.7%)
SDOC 152 (1.7%) 3 (0.3%) 79 (1.6%) 28 (1.0%) 24 (15.3%) 18 (9.5%)
Modified sarcopenia definitions
EWGSOP2 505 (5.5%) 73 (8.0%) 282 (5.6%) 123 (4.3%) 5 (3.2%) 22 (11.6%)
SDOC 487 (5.3%) 28 (3.1%) 283 (5.6%) 88 (3.1%) 52 (33.1%) 36 (18.9%)
Died during follow‐up 5929 (64.7%) 627 (69.1%) 3255 (64.3%) 1973 (69.2%) 28 (17.8%) 46 (24.2%)
Follow‐up time (years) 12.1 (5.5) 11.6 (4.9) 13.0 (5.7) 11.4 (4.8) 6.4 (1.2) 4.4 (1.1)

ALM, appendicular lean mass; EWGSOP2, 2019 European Working Group on Sarcopenia in Older People; HCS, Hertfordshire Cohort Study; Health ABC, Health, Aging and Body Composition Study; MrOS, Osteoporotic Fractures in Men Study; SarcoPhAge, Sarcopenia and Physical impairment with advancing Age Study; SDOC, Sarcopenia Definitions and Outcomes Consortium.

Thresholds for original and modified definitions are presented in Table 1.